Adamas Pharmaceuticals, Inc

(NASDAQ:ADMS)

Latest On Adamas Pharmaceuticals, Inc (ADMS):

Date/Time Type Description Signal Details
2021-10-27 12:17 ESTNewsAdamas Pharmaceuticals: An Acceptable Buyout At The Perfect TimeN/A
2021-10-16 03:15 ESTNewsJasper more than doubles while M&A headlines weekly healthcare performersN/A
2021-10-12 00:48 ESTNewsSupernus to acquire Adamas in a deal worth up to $850 millionN/A
2021-10-12 00:46 ESTNewsAs Supernus acquires Adamas, other Parkinson's players mixed on the dayN/A
2021-08-09 22:16 ESTNewsAdamas Pharma EPS beats by $0.02, beats on revenueN/A
2021-08-09 22:15 ESTNewsAdamas Pharmaceuticals, Inc. (ADMS) CEO Neil McFarlane on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-22 18:19 ESTNewsAdamas secures new patents for Gocovri and ADS-4101N/A
2021-07-20 17:48 ESTNewsAnalysis finds Adamas Parkinson's drug provides motor activity improvementsN/A
2021-07-20 17:33 ESTNewsAdamas Pharmaceuticals: Share Price Range-Bound Despite Steady Revenue GrowthN/A
2021-04-14 20:47 ESTNewsCircling Back On Adamas PharmaceuticalsN/A
2021-03-30 01:02 ESTNewsAdamas announces new peer-reviewed data to support Gocovri benefit in Parkinson’sN/A
2021-03-01 03:01 ESTAnalyst RatingThe Analyst Target Price has decreased from $10.69 to $10.44.Neutral
2021-02-25 18:35 ESTNewsAdamas Pharmaceuticals stock under pressure on $55M equity raiseN/A
2021-02-25 18:33 ESTNewsAdamas Pharmaceuticals, Inc. 2020 Q4 - Results - Earnings Call PresentationN/A
2021-02-25 03:02 ESTAnalyst RatingThe Analyst Target Price has increased from $10.56 to $10.69.Buy
2021-02-24 21:17 ESTNewsAdamas Pharmaceuticals launches follow-on public offeringN/A
2021-02-24 11:02 ESTFinancialsCompany financials have been released.Neutral
2021-02-24 03:16 ESTNewsAdamas Pharma EPS misses by $0.14, beats on revenueN/A
2021-02-24 03:15 ESTNewsAdamas Pharmaceuticals' (ADMS) CEO Neil McFarlane on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-24 03:01 ESTEarnings EstimateAn EPS average of -$0.82 is estimated for the 2022 year.Sell
2021-02-24 03:01 ESTEarnings EstimateAn EPS average of -$0.34 is estimated for the quarter ending on June 30, 2021.Buy
2021-02-10 15:02 ESTAnalyst RatingThe Analyst Target Price has increased from $10.44 to $10.56.Buy
2021-02-05 15:01 ESTAnalyst RatingThe Analyst Target Price has increased from $10.06 to $10.44.Buy
2021-02-03 03:01 ESTAnalyst RatingThe Analyst Target Price has increased from $9.81 to $10.06.Buy
2021-02-02 03:02 ESTNewsAdamas Pharmaceuticals trading halted for news pendingN/A
2021-02-02 03:02 ESTNewsAdamas' stock jumps on GOCOVRI's expanded FDA approvalN/A
2021-02-01 09:00 ESTNewsAdamas gains 12% on settlement of patent litigation with ZydusN/A
2021-01-30 23:00 ESTNewsAdamas: How We Got Here And What The Future BringsN/A
2021-01-29 07:02 ESTAnalyst RatingThe Analyst Target Price has increased from $9.19 to $9.81.Buy
2021-01-13 09:45 ESTNewsAdamas Pharmaceuticals provides preliminary Q4 and FY figuresN/A
2020-12-13 03:02 ESTFinancialsCompany financials have been released.Neutral
2020-12-02 14:48 ESTNewsAdamas Pharma settles patent dispute with Osmotica for $7.5MN/A
2020-12-02 14:48 ESTNewsAdamas Pharma amends royalty-backed loan deal with Healthcare Royalty PartnersN/A
2020-11-25 11:04 ESTFinancialsCompany financials have been released.Neutral
2020-11-13 20:05 ESTNewsAdamas Pharmaceuticals: Unjustified Sell-Off Following Another Strong QuarterN/A
2020-11-09 11:03 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 03:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $9.31 to $9.19.Neutral
2020-11-08 17:01 ESTNewsAdamas Pharmaceuticals' (ADMS) CEO Neil McFarlane on Q3 2020 Results -Earnings Call TranscriptN/A
2020-11-06 15:02 ESTEarnings EstimateAn EPS average of -$0.41 is estimated for the quarter ending on March 31, 2021.Buy
2020-11-06 01:17 ESTNewsAdamas Pharma EPS beats by $0.05, misses on revenueN/A
2020-11-02 17:00 ESTInsider TradeChristopher B Prentiss has directly disposed of 2,050 shares and currently holds 78,890 shares.Sell
2020-11-01 16:50 ESTFinancialsCompany financials have been released.Neutral
2020-10-02 11:51 ESTNewsAdamas Pharma names new CMON/A
2020-09-26 04:03 ESTFinancialsCompany financials have been released.Neutral
2020-09-24 16:03 ESTFinancialsCompany financials have been released.Neutral
2020-09-01 17:00 ESTInsider TradeANNA RICHO has directly acquired 10,000 shares and currently holds 20,000 shares.Buy
2020-08-13 10:04 ESTNewsAdamas Pharmaceuticals: Feeling Bullish After Impressive Growth In Q2N/A
2020-08-12 04:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $9.44 to $9.31.Neutral
2020-08-11 08:02 ESTFinancialsCompany financials have been released.Neutral
2020-08-09 08:02 ESTFinancialsCompany financials have been released.Neutral

About Adamas Pharmaceuticals, Inc (ADMS):

Adamas Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of medicines for patients suffering from chronic neurologic disorders in the United States. It offers GOCOVRI, an extended release capsule for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications, as well as an adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease experiencing OFF episodes; and OSMOLEX ER, an extended release tablet to treat Parkinson's disease and drug-induced extrapyramidal reactions in adult patients. The company is also developing ADS-4101, which has completed two Phase 1b studies for treating partial onset seizures in patients with epilepsy. In addition, it offers NAMZARIC and NAMENDA XR, a memantine hydrochloride extended release and donepezil hydrochloride capsules for the treatment of moderate to severe dementia of an Alzheimer's type. The company was formerly known as NeuroMolecular Pharmaceuticals, Inc. and changed its name to Adamas Pharmaceuticals, Inc. in July 2007. Adamas Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

ADMS Quotes by TradingView

See Advanced Chart

General

  • Name Adamas Pharmaceuticals, Inc
  • Symbol ADMS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 138
  • Fiscal Year EndDecember
  • IPO Date2014-04-10
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.adamaspharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 2.09
  • Enterprise Value Revenue 4.03
  • Enterprise Value EBITDA 0.11
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.61
  • Next Year EPS Estimate -$0.88
  • Next Quarter EPS Estimate -$0.45
  • Profit Margin -77%
  • Operating Margin -53%
  • Return on Assets -17%
  • Revenue 74.46 million
  • Earnings Per Share -$4.25
  • Revenue Per Share $2.63
  • Gross Profit 72.42 million
  • Quarterly Earnings Growth 28.5%
View More

Highlights

  • Market Capitalization 248.54 million
  • EBITDA -101027000
  • PEG Ratio -0.06
  • Analyst Target Price $10.44
  • Book Value Per Share $0.71
View More

Share Statistics

  • Shares Outstanding 44.94 million
  • Shares Float 22.54 million
  • % Held by Insiders 274%
  • % Held by Institutions 68.33%
  • Shares Short 1.99 million
  • Shares Short Prior Month 923484
  • Short Ratio 1.41
  • Short % of Float 8%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • Beta 2.68
  • 52 Week High $9.15
  • 52 Week Low $2.31
  • 50 Day Moving Average 5.49
  • 200 Day Moving Average 4.7
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Adamas Pharmaceuticals, Inc (ADMS) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Adamas Pharmaceuticals, Inc (ADMS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-23$21.01 million-$0.64-$0.52-23.67%
2020-09-302020-11-05$N/A-$0.42-$0.4812.95%
2020-06-302020-08-06$N/A-$0.37-$0.6139.34%
2020-03-312020-05-07$14.48 million-$0.59-$0.7723.38%
2019-12-312020-02-25$16.35 million-$0.83-$0.830.3%
2019-09-302019-11-07$13.93 million-$0.99-$0.87-13.36%
2019-06-302019-08-08$12.69 million-$0.90-$0.998.63%
2019-03-312019-05-09$11.67 million-$1.08-$1.155.73%
2018-12-312019-03-04$13.32 million-$1.06-$1.3219.7%
2018-09-302018-11-01$10.61 million-$1.22-$1.349.16%
2018-06-302018-08-02$7.57 million-$1.26-$1.4110.78%
2018-03-312018-05-03$2.55 million-$1.35-$1.371.36%
2017-12-312018-02-22$568000-$1.28-$1.18-8.6%
2017-09-302017-11-02$1000-$1.04-$0.98-6.48%
2017-06-302017-08-08$2000-$0.93-$0.81-15.28%
2017-03-312017-05-09$N/A-$0.72-$0.71-1.88%
2016-12-312017-02-28$37000-$0.68-$0.8015.42%
2016-09-302016-11-03$138000-$0.66-$0.8320.07%
2016-06-302016-08-04$222000-$0.78-$0.71-10.23%
2016-03-312016-05-10$175000-$0.65-$0.7412.16%
2015-12-312016-02-23$524000-$0.58-$0.8632.87%
2015-09-302015-11-12$768000-$0.81-$0.832.41%
2015-06-302015-08-11$398000-$0.78-$0.72-8.33%
2015-03-312015-05-13$226000-$0.69-$0.746.76%
2014-12-312015-03-03$30.3 million$0.50-$0.24308.33%
2014-09-302014-11-04$215000-$0.57-$0.44-29.55%
2014-06-302014-08-07$25.15 million$0.88$0.818.64%
2014-03-312014-05-14$176000-$0.67

Adamas Pharmaceuticals, Inc (ADMS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Adamas Pharmaceuticals, Inc (ADMS) Chart:

ADMS chart by TradingView

Adamas Pharmaceuticals, Inc (ADMS) News:

Below you will find a list of latest news for Adamas Pharmaceuticals, Inc (ADMS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Adamas Pharmaceuticals, Inc (ADMS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Adamas Pharmaceuticals, Inc (ADMS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000132814320000036/0001328143-20-000036-index.htm
2019-09-19UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1328143/000000000019013748/0000000000-19-013748-index.htm
2019-10-15UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1328143/000000000019014560/0000000000-19-014560-index.htm
2019-11-20UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1328143/000000000019015664/0000000000-19-015664-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1328143/000009375119000043/0000093751-19-000043-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1328143/000021545719006712/0000215457-19-006712-index.htm
2018-10-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1328143/000031506618002417/0000315066-18-002417-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1328143/000083423720004693/0000834237-20-004693-index.htm
2020-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1328143/000083423720009908/0000834237-20-009908-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1328143/000089914019000204/0000899140-19-000204-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1328143/000089914020000165/0000899140-20-000165-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1328143/000091420819000068/0000914208-19-000068-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1328143/000091420820000025/0000914208-20-000025-index.htm
2019-01-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1328143/000091957419000649/0000919574-19-000649-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1328143/000091957419001196/0000919574-19-001196-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1328143/000091957420001124/0000919574-20-001124-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1328143/000091957420001498/0000919574-20-001498-index.htm
2019-06-19SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1328143/000093583619000346/0000935836-19-000346-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1328143/000093583620000104/0000935836-20-000104-index.htm
2019-01-02SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1328143/000117266119000002/0001172661-19-000002-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1328143/000119312519040928/0001193125-19-040928-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1328143/000119312520034818/0001193125-20-034818-index.htm
2018-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919118036396/0001209191-18-036396-index.htm
2018-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919118036405/0001209191-18-036405-index.htm
2018-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919118036414/0001209191-18-036414-index.htm
2018-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919118036418/0001209191-18-036418-index.htm
2018-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919118036426/0001209191-18-036426-index.htm
2018-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919118036428/0001209191-18-036428-index.htm
2018-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919118036430/0001209191-18-036430-index.htm
2018-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919118039249/0001209191-18-039249-index.htm
2018-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919118039257/0001209191-18-039257-index.htm
2018-09-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919118051991/0001209191-18-051991-index.htm
2018-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919118057797/0001209191-18-057797-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919118063937/0001209191-18-063937-index.htm
2018-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919118064120/0001209191-18-064120-index.htm
2018-12-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919118064320/0001209191-18-064320-index.htm
2019-03-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119020763/0001209191-19-020763-index.htm
2019-03-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119020769/0001209191-19-020769-index.htm
2019-03-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119020779/0001209191-19-020779-index.htm
2019-03-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119020785/0001209191-19-020785-index.htm
2019-03-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119020792/0001209191-19-020792-index.htm
2019-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119024239/0001209191-19-024239-index.htm
2019-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119024240/0001209191-19-024240-index.htm
2019-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119024242/0001209191-19-024242-index.htm
2019-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119024244/0001209191-19-024244-index.htm
2019-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119024248/0001209191-19-024248-index.htm
2019-06-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119034483/0001209191-19-034483-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119035047/0001209191-19-035047-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119035051/0001209191-19-035051-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119035054/0001209191-19-035054-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119035058/0001209191-19-035058-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119035061/0001209191-19-035061-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119035064/0001209191-19-035064-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119035069/0001209191-19-035069-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119035685/0001209191-19-035685-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119038602/0001209191-19-038602-index.htm
2019-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119042978/0001209191-19-042978-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119049493/0001209191-19-049493-index.htm
2019-09-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119049927/0001209191-19-049927-index.htm
2019-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119049941/0001209191-19-049941-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119050078/0001209191-19-050078-index.htm
2019-09-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119050455/0001209191-19-050455-index.htm
2019-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919119055838/0001209191-19-055838-index.htm
2020-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919120004717/0001209191-20-004717-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919120020266/0001209191-20-020266-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919120020269/0001209191-20-020269-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919120020527/0001209191-20-020527-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919120034775/0001209191-20-034775-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919120034776/0001209191-20-034776-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919120034777/0001209191-20-034777-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919120034779/0001209191-20-034779-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919120034782/0001209191-20-034782-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919120034809/0001209191-20-034809-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919120034864/0001209191-20-034864-index.htm
2020-09-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919120048933/0001209191-20-048933-index.htm
2020-09-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919120048935/0001209191-20-048935-index.htm
2020-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1328143/000120919120056424/0001209191-20-056424-index.htm
2019-03-01SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1328143/000131924419000031/0001319244-19-000031-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1328143/000131924420000040/0001319244-20-000040-index.htm
2018-10-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000132814318000004/0001328143-18-000004-index.htm
2018-11-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1328143/000132814318000005/0001328143-18-000005-index.htm
2018-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000132814318000006/0001328143-18-000006-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000132814319000002/0001328143-19-000002-index.htm
2019-03-0410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1328143/000132814319000011/0001328143-19-000011-index.htm
2019-03-04S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1328143/000132814319000013/0001328143-19-000013-index.htm
2019-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000132814319000014/0001328143-19-000014-index.htm
2019-04-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000132814319000016/0001328143-19-000016-index.htm
2019-04-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1328143/000132814319000019/0001328143-19-000019-index.htm
2019-04-25DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1328143/000132814319000020/0001328143-19-000020-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1328143/000132814319000026/0001328143-19-000026-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000132814319000027/0001328143-19-000027-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000132814319000029/0001328143-19-000029-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1328143/000132814319000035/0001328143-19-000035-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000132814319000036/0001328143-19-000036-index.htm
2019-09-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000132814319000038/0001328143-19-000038-index.htm
2019-10-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1328143/000132814319000040/0001328143-19-000040-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1328143/000132814319000049/0001328143-19-000049-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000132814319000050/0001328143-19-000050-index.htm
2019-11-07S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1328143/000132814319000051/0001328143-19-000051-index.htm
2019-11-21CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1328143/000132814319000053/0001328143-19-000053-index.htm
2019-11-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1328143/000132814319000055/0001328143-19-000055-index.htm
2019-12-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1328143/000132814319000058/0001328143-19-000058-index.htm
2019-12-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1328143/000132814319000059/0001328143-19-000059-index.htm
2020-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000132814320000002/0001328143-20-000002-index.htm
2020-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000132814320000004/0001328143-20-000004-index.htm
2020-02-2510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1328143/000132814320000012/0001328143-20-000012-index.htm
2020-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000132814320000013/0001328143-20-000013-index.htm
2020-02-25S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1328143/000132814320000015/0001328143-20-000015-index.htm
2020-04-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1328143/000132814320000018/0001328143-20-000018-index.htm
2020-04-23DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1328143/000132814320000020/0001328143-20-000020-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1328143/000132814320000028/0001328143-20-000028-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000132814320000029/0001328143-20-000029-index.htm
2020-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000132814320000032/0001328143-20-000032-index.htm
2020-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000132814320000034/0001328143-20-000034-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000132814320000036/0001328143-20-000036-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1328143/000132814320000042/0001328143-20-000042-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000132814320000043/0001328143-20-000043-index.htm
2020-09-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000132814320000045/0001328143-20-000045-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1328143/000132814320000050/0001328143-20-000050-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000132814320000052/0001328143-20-000052-index.htm
2020-11-05S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1328143/000132814320000054/0001328143-20-000054-index.htm
2020-08-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1328143/000149315220016532/0001493152-20-016532-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1328143/000160454119000002/0001604541-19-000002-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1328143/000160454120000003/0001604541-20-000003-index.htm
2018-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1328143/000162828018005106/0001628280-18-005106-index.htm
2018-04-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1328143/000162828018005107/0001628280-18-005107-index.htm
2018-05-0310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1328143/000162828018005826/0001628280-18-005826-index.htm
2018-05-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000162828018005830/0001628280-18-005830-index.htm
2018-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000162828018007648/0001628280-18-007648-index.htm
2018-08-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1328143/000162828018010334/0001628280-18-010334-index.htm
2018-08-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000162828018010338/0001628280-18-010338-index.htm
2018-09-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000162828018011880/0001628280-18-011880-index.htm
2018-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1328143/000162828018012035/0001628280-18-012035-index.htm
2019-12-02EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1328143/999999999519002725/9999999995-19-002725-index.htm
2019-09-11SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1328143/999999999719006771/9999999997-19-006771-index.htm
2019-09-26SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1328143/999999999719007128/9999999997-19-007128-index.htm

Adamas Pharmaceuticals, Inc (ADMS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Adamas Pharmaceuticals, Inc (ADMS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 274%
Institutional Ownership: 6833%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-09-16Neil F. McFarlaneChief Executive OfficerBuy125,000.00125,000.00https://www.sec.gov/Archives/edgar/data/1328143/000120919119049941/0001209191-19-049941-index.htm
2019-03-20Gregory T WentChief Executive OfficerSell6,319.007.9950,488.81176,291.00https://www.sec.gov/Archives/edgar/data/1328143/000120919119020763/0001209191-19-020763-index.htm
2018-12-20Christopher B PrentissChief Accounting OfficerSell228.007.511,712.2818,226.00https://www.sec.gov/Archives/edgar/data/1328143/000120919118064120/0001209191-18-064120-index.htm
2019-03-20Rajiv PatniChief Medical OfficerSell2,374.008.0018,992.0019,141.00https://www.sec.gov/Archives/edgar/data/1328143/000120919119020785/0001209191-19-020785-index.htm
2018-11-07Gregory T WentChief Executive OfficerBuy3,850.0012.9849,956.45199,242.00https://www.sec.gov/Archives/edgar/data/1328143/000120919118057797/0001209191-18-057797-index.htm
2020-08-29ANNA RICHODirectorBuy10,000.0020,000.00https://www.sec.gov/Archives/edgar/data/1328143/000120919120048935/0001209191-20-048935-index.htm
2020-03-18Neil F. McFarlaneChief Executive OfficerBuy100,000.00225,000.00https://www.sec.gov/Archives/edgar/data/1328143/000120919120020527/0001209191-20-020527-index.htm
2019-04-08Gregory T WentChief Executive OfficerBuy56,250.00232,541.00https://www.sec.gov/Archives/edgar/data/1328143/000120919119024248/0001209191-19-024248-index.htm
2019-03-20ALFRED G MERRIWEATHERChief Financial OfficerSell857.007.996,847.4324,603.00https://www.sec.gov/Archives/edgar/data/1328143/000120919119020792/0001209191-19-020792-index.htm
2018-09-21ALFRED G MERRIWEATHERChief Financial OfficerSell1,665.0019.1831,934.7025,460.00https://www.sec.gov/Archives/edgar/data/1328143/000120919118051991/0001209191-18-051991-index.htm
2019-03-20Christopher B PrentissChief Accounting OfficerSell1,185.008.009,480.0029,541.00https://www.sec.gov/Archives/edgar/data/1328143/000120919119020779/0001209191-19-020779-index.htm
2018-12-27Christopher B PrentissChief Accounting OfficerBuy12,500.0030,726.00https://www.sec.gov/Archives/edgar/data/1328143/000120919118064320/0001209191-18-064320-index.htm
2019-03-20Jennifer J RhodesCBO, GC & Compliance OfficerSell1,792.007.9914,318.0831,612.00https://www.sec.gov/Archives/edgar/data/1328143/000120919119020769/0001209191-19-020769-index.htm
2018-12-20Jennifer J RhodesCBO, GC & Compliance OfficerSell425.007.523,196.0033,404.00https://www.sec.gov/Archives/edgar/data/1328143/000120919118063937/0001209191-18-063937-index.htm
2018-06-21Jennifer J RhodesCBO, GC & Compliance OfficerSell1,002.0025.4825,530.9633,794.00https://www.sec.gov/Archives/edgar/data/1328143/000120919118039257/0001209191-18-039257-index.htm
2019-07-22Christopher B PrentissChief Accounting OfficerSell1,082.006.006,492.0047,209.00https://www.sec.gov/Archives/edgar/data/1328143/000120919119042978/0001209191-19-042978-index.htm
2019-09-20ALFRED G MERRIWEATHERChief Financial OfficerSell1,584.006.9110,945.4448,019.00https://www.sec.gov/Archives/edgar/data/1328143/000120919119050455/0001209191-19-050455-index.htm
2019-04-08Christopher B PrentissChief Accounting OfficerBuy18,750.0048,291.00https://www.sec.gov/Archives/edgar/data/1328143/000120919119024242/0001209191-19-024242-index.htm
2018-06-21RICHARD KINGChief Operating OfficerSell2,501.0025.4863,725.4848,856.00https://www.sec.gov/Archives/edgar/data/1328143/000120919118039249/0001209191-18-039249-index.htm
2019-04-08Rajiv PatniChief Medical OfficerBuy30,000.0049,141.00https://www.sec.gov/Archives/edgar/data/1328143/000120919119024240/0001209191-19-024240-index.htm
2019-04-08ALFRED G MERRIWEATHERChief Financial OfficerBuy25,000.0049,603.00https://www.sec.gov/Archives/edgar/data/1328143/000120919119024239/0001209191-19-024239-index.htm
2020-06-03John A MacPheeDirectorBuy5,000.005,000.00https://www.sec.gov/Archives/edgar/data/1328143/000120919120034779/0001209191-20-034779-index.htm
2020-06-03Mardi DierDirectorBuy5,000.005,000.00https://www.sec.gov/Archives/edgar/data/1328143/000120919120034777/0001209191-20-034777-index.htm
2020-06-03MARTHA J DEMSKIDirectorBuy5,000.005,000.00https://www.sec.gov/Archives/edgar/data/1328143/000120919120034776/0001209191-20-034776-index.htm
2020-06-03MICHAEL BIGHAMDirectorBuy5,000.005,000.00https://www.sec.gov/Archives/edgar/data/1328143/000120919120034775/0001209191-20-034775-index.htm
2020-06-03William W. EricsonDirectorBuy5,000.005,000.00https://www.sec.gov/Archives/edgar/data/1328143/000120919120034864/0001209191-20-034864-index.htm
2020-06-03IVAN M LIEBERBURGDirectorBuy5,000.0053,000.00https://www.sec.gov/Archives/edgar/data/1328143/000120919120034809/0001209191-20-034809-index.htm
2019-09-17DAVID L MAHONEYDirectorBuy33,332.001.7658,497.6657,153.00https://www.sec.gov/Archives/edgar/data/1328143/000120919119050078/0001209191-19-050078-index.htm
2019-04-08Jennifer J RhodesCBO, GC & Compliance OfficerBuy30,000.0061,612.00https://www.sec.gov/Archives/edgar/data/1328143/000120919119024244/0001209191-19-024244-index.htm
2020-06-03DAVID L MAHONEYDirectorBuy5,000.0062,153.00https://www.sec.gov/Archives/edgar/data/1328143/000120919120034782/0001209191-20-034782-index.htm
2019-06-20Jennifer J RhodesCBO, GC & Compliance OfficerSell940.005.355,029.0063,114.00https://www.sec.gov/Archives/edgar/data/1328143/000120919119038602/0001209191-19-038602-index.htm
2019-06-07Vijay ShreedharChief Commercial OfficerBuy68,750.0068,750.00https://www.sec.gov/Archives/edgar/data/1328143/000120919119035685/0001209191-19-035685-index.htm
2020-01-21Christopher B PrentissChief Financial OfficerSell1,269.005.927,512.4870,940.00https://www.sec.gov/Archives/edgar/data/1328143/000120919120004717/0001209191-20-004717-index.htm
2019-11-07Christopher B PrentissChief Financial OfficerBuy25,000.0072,209.00https://www.sec.gov/Archives/edgar/data/1328143/000120919119055838/0001209191-19-055838-index.htm
2020-11-02Christopher B PrentissChief Financial OfficerSell2,050.003.216,580.5078,890.00https://www.sec.gov/Archives/edgar/data/1328143/000120919120056424/0001209191-20-056424-index.htm
2020-03-17Christopher B PrentissChief Financial OfficerBuy10,000.0080,940.00https://www.sec.gov/Archives/edgar/data/1328143/000120919120020266/0001209191-20-020266-index.htm
2020-03-17Vijay ShreedharChief Commercial OfficerBuy23,750.0095,000.00https://www.sec.gov/Archives/edgar/data/1328143/000120919120020269/0001209191-20-020269-index.htm